Dr. Waintraub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd St
Hackensack, NJ 07601Phone+1 551-996-5864Fax+1 551-996-0578
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1980 - 1981
- New York Medical College (Metropolitan)Residency, Internal Medicine, 1978 - 1980
- New York Medical CollegeClass of 1977
- Brooklyn College of CUNYB.S., 1974
Certifications & Licensure
- NY State Medical License 1978 - 2026
- NJ State Medical License 1983 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2010-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Join now to see all
Clinical Trials
- Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Publications & Presentations
PubMed
- 58 citationsNonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.Jeffrey S. Ross, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin
Cancer. 2016-09-01 - 9 citationsDifferential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.Donna M. McNamara, Stuart L. Goldberg, Lisa M. Latts, Deena Graham, Stanley E. Waintraub
Cancer Medicine. 2019-09-11 - 142 citationsUnusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue a...Stuart L. Goldberg, Andrew L. Pecora, Robert S. Alter, Mark S. Kroll, Scott D. Rowley
Blood. 2002-02-15
Journal Articles
- The Use of Anti-D In Immune Thrombocytopenic Purpura As A Means To Prevent Splenectomy Case Reports From Two University Hospital Medical CentersWaintraub, S.E. and Brody, J.I., Seminars In Hematology, 1/1/2009
- Colonic adenomas detected by FDG PET scansFelig DM, Sedarat A, Agress H, Waintraub SE, Gastrointestinal Endoscopy, 1/1/2002
- Phase II Study To Evaluate The Efficacy of Weekly Paclitaxel (P) In Patients With Metastatic Breast Cancer (MBC) Who Have Failed Prior Anthracycline (A) +/- Taxane (T)...S.E. Waintraub, S. Cantwell, J. DeVries,, JCO, 1/1/1999
- Join now to see all
Abstracts/Posters
- The role of preoperative neoadjuvant cytoreductive dose dense bevacizumab plus docetaxel followed by bevacizumab-doxorubicin-cyclophosphamide regimen in locally advanc...Waintraub, SE, Tuchman, V, Proceedings of ASCO, 1/1/2009
- The role of maintenance bevacizumab in patients with metastatic breast cancer treated with chemotherapy and bevacizumab upon achieving complete response or maximal rad...Waintraub SE, Tuchman V, ASCO, 1/1/2008
- Phase II Trial To Study The Efficacy And Toxicity Of Combined Docetaxel, Carboplatin, Plus Or Minus Trastuzumab Administered Weekly In Patients With HER2/neu Positive/...Waintraub D, Sica V, Proceedings of ASCO, 1/1/2004
- Join now to see all
Press Mentions
- Genetic Testing Helps Entire New Jersey Family Avoid CancersSeptember 22nd, 2021
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: